Serglycin, which is secreted by NSCLC, mediates this effect via the interaction of its CS with CD44 and the induction of Nanog signaling, thereby stimulating cancer cells’ stemness and enhancing their chemoresistance 150 (Fig. 3). Here, SRGN is linked to cancer.